Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses

BMC Genomics

Volumn 16, Issue 7, 2015, Pages

  Nguyen, Nguyen T ^a,b   Lindsey, Merry L ^b,c,d   Jin, Yu Fang ^a,b  

^a The University of Texas at San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALGORITHM; ARTICLE; BLOOD CLOTTING; GENE ONTOLOGY; HEART INFARCTION; MATHEMATICAL ANALYSIS; MOLECULAR INTERACTION; PREDICTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SYSTEM ANALYSIS; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM;

ALGORITHMS; DATABASES, GENETIC; GENE ONTOLOGY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MYOCARDIAL INFARCTION;

EID: 84969271155     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-16-S7-S18     Document Type: Article

References (95)

1. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28 (1): 27-30. 10.1093/nar/28.1.27.
2. Nishimura D: BioCarta. Biotech Software & Internet Report. 2001, 2 (3): 117-120. 10.1089/152791601750294344.
3. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR, et al: The Reactome pathway knowledgebase. Nucleic Acids Res. 2014, 42 (Database): D472-477.
4. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer K, Muruganujan A, Narechania A: PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13 (9): 2129-2141. 10.1101/gr.772403.
5. Caspi R, Altman T, Billington R, Dreher K, Foerster H, Fulcher CA, Holland TA, Keseler IM, Kothari A, Kubo A, et al: The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 2014, 42 (Database): D459-471.
6. Eichner J, Rosenbaum L, Wrzodek C, Haring HU, Zell A, Lehmann R: Integrated enrichment analysis and pathway-centered visualization of metabolomics, proteomics, transcriptomics, and genomics data by using the InCroMAP software. J Chromatogr B Analyt Technol Biomed Life Sci. 2014, 966: 77-82.
7. Gruden K, Hren M, Herman A, Blejec A, Albrecht T, Selbig J, Bauer C, Schuchardt J, Or-Guil M, Zupancic K, et al: A crossomics study analysing variability of different components in peripheral blood of healthy caucasoid individuals. PLoS One. 2012, 7 (1): e28761-10.1371/journal.pone.0028761.
8. Amiour N, Imbaud S, Clement G, Agier N, Zivy M, Valot B, Balliau T, Armengaud P, Quillere I, Canas R, et al: The use of metabolomics integrated with transcriptomic and proteomic studies for identifying key steps involved in the control of nitrogen metabolism in crops such as maize. Journal of Experimental Botany. 2012, 63 (14): 5017-5033. 10.1093/jxb/ers186.
9. Babur O, Dogrusoz U, Cakir M, Aksoy BA, Schultz N, Sander C, Demir E: Integrating biological pathways and genomic profiles with ChiBE 2. BMC Genomics. 2014, 15: 642-10.1186/1471-2164-15-642.
10. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25 (1): 25-29. 10.1038/75556.
11. Nguyen NT, Zhang X, Wu C, Lange RA, Chilton RJ, Lindsey ML, Jin YF: Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map. PLoS Comput Biol. 2014, 10 (3): e1003472-10.1371/journal.pcbi.1003472.
12. Huang dW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009, 4 (1): 44-57.
13. Cohen J: A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas. 1960, 20 (1): 37-46. 10.1177/001316446002000104.
14. Carlson M: GO.db: A set of annotation maps describing the entire Gene Ontology. 2013
15. Csardi G NT: The igraph software package for complex network research. InterJournal,. 2006, Complex Systems(1695)
16. Gould L, Reddy CV, Swamy CR, Oh KC, Kim SG: Decline of serum phosphorus in acute myocardial infarction. Angiology. 1979, 30 (4): 219-222. 10.1177/000331977903000401.
17. Aronson D, Kapeliovich M, Hammerman H, Dragu R: The Relation between Serum Phosphorus Levels and Clinical Outcomes after Acute Myocardial Infarction. PLoS One. 2013, 8 (3):
18. Vaidyanathan D, Venkatesan S, Ramadesikan VK: Serum phosphate in acute myocardial infarction. Indian J Physiol Pharmacol. 2000, 44 (2): 225-228.
19. Knapp M, Baranowski M, Czarnowski D, Lisowska A, Zabielski P, Gorski J, Musial W: Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. Med Sci Monitor. 2009, 15 (9): Cr490-Cr493.
20. Darsee JR, Heymsfield SB, Nutter DO: Hypertrophic cardiomyopathy and human leukocyte antigen linkage: differentiation of two forms of hypertrophic cardiomyopathy. N Engl J Med. 1979, 300 (16): 877-882. 10.1056/NEJM197904193001602.
21. Nutter DO, Heymsfield SB, Glenn JF: Retraction. Darsee JR, Heymsfield SB, Nutter DO. Hypertrophic cardiomyopathy and human leukocyte antigen linkage: differentiation of two forms of hypertrophic cardiomyopathy. N Engl J Med 1979;300:877-82. N Engl J Med. 1983, 308 (23): 1400-
22. Lozano MD, Rubocki RJ, Wilson JE, McManus BM, Wisecarver JL: Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis Treatment Trial Investigators. J Card Fail. 1997, 3 (2): 97-103. 10.1016/S1071-9164(97)90041-5.
23. Li X, Luo R, Jiang R, Chen R, Hua W: Human leukocyte antigen-DQ beta 1 chain (DQB1) gene polymorphisms are associated with dilated cardiomyopathy: a systematic review and meta-analysis. Heart Lung. 2012, 41 (4): 360-367. 10.1016/j.hrtlng.2012.01.005.
24. Heissig B, Lund LR, Akiyama H, Ohki M, Morita Y, Romer J, Nakauchi H, Okumura K, Ogawa H, Werb Z, et al: The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. Cell Stem Cell. 2007, 1 (6): 658-670. 10.1016/j.stem.2007.10.012.
25. Heidt T, Sager HB, Courties G, Dutta P, Iwamoto Y, Zaltsman A, von Zur Muhlen C, Bode C, Fricchione GL, Denninger J, et al: Chronic variable stress activates hematopoietic stem cells. Nat Med. 2014, 20 (7): 754-758. 10.1038/nm.3589.
26. Armstrong PW, Collen D, Antman E: Fibrinolysis for acute myocardial infarction: the future is here and now. Circulation. 2003, 107 (20): 2533-2537. 10.1161/01.CIR.0000072930.64775.DC.
27. Gilutz H, Siegel Y, Paran E, Cristal N, Quastel MR: Alpha 1-antitrypsin in acute myocardial infarction. Br Heart J. 1983, 49 (1): 26-29. 10.1136/hrt.49.1.26.
28. Toldo S, Seropian IM, Mezzaroma E, Van Tassell BW, Salloum FN, Lewis EC, Voelkel N, Dinarello CA, Abbate A: Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol. 2011, 51 (2): 244-251. 10.1016/j.yjmcc.2011.05.003.
29. Gonzalez-Nunez M, Munoz-Felix JM, Lopez-Novoa JM: The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?. Biochim Biophys Acta. 2013, 1832 (10): 1492-1510. 10.1016/j.bbadis.2013.05.016.
30. Tian F, Zhou AX, Smits AM, Larsson E, Goumans MJ, Heldin CH, Boren J, Akyurek LM: Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro. Biochem Biophys Res Commun. 2010, 392 (3): 283-288. 10.1016/j.bbrc.2009.12.170.
31. Shimoda Y, Satoh M, Nakamura M, Akatsu T, Hiramori K: Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction. Clinical science. 2005, 108 (4): 339-347. 10.1042/CS20040229.
32. Satoh M, Ishikawa Y, Itoh T, Minami Y, Takahashi Y, Nakamura M: The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction. Eur J Clin Invest. 2008, 38 (2): 97-105. 10.1111/j.1365-2362.2007.01912.x.
33. Nakayama T, Soma M, Saito S, Honye J, Sato M, Aoi N, Kosuge K, Haketa A, Kanmatsuse K, Kokubun S: Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction. Medical science monitor : international medical journal of experimental and clinical research. 2003, 16 (12): CR505-510.
34. Nakanishi M, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakagawa Y, Tanimoto K, Yasuno S, et al: Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice. Hypertension. 2005, 46 (2): 441-447. 10.1161/01.HYP.0000173420.31354.ef.
35. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, et al: Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008, 372 (9634): 224-233. 10.1016/S0140-6736(08)61076-4.
36. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG: Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality. Scand J Clin Lab Invest. 2011, 71 (2): 87-93.
37. Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP: Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. Am J Physiol Heart Circ Physiol. 2011, 300 (41): H1274-1281.
38. Shivshankar P, Halade GV, Calhoun C, Escobar GP, Mehr AJ, Jimenez F, Martinez C, Bhatnagar H, Mjaatvedt CH, Lindsey ML, et al: Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction. J Mol Cell Cardiol. 2014, 84-93. 76C
39. Juhan-Vague I, Morange PE, Aubert H, Henry M, Aillaud MF, Alessi MC, Samnegard A, Hawe E, Yudkin J, Margaglione M, et al: Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol. 2002, 22 (5): 867-873. 10.1161/01.ATV.0000015445.22243.F4.
40. Kraft P, Schwarz T, Meijers JC, Stoll G, Kleinschnitz C: Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke. PLoS One. 2010, 5 (7): e11658-10.1371/journal.pone.0011658.
41. Pellikka M, Narhi L, Perola M, Penttila A, Karhunen PJ, Mikkelsson J: Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men. Journal of thrombosis and thrombolysis. 2008, 26 (2): 91-96. 10.1007/s11239-007-0072-2.
42. Knowles JW, Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Quertermous T, Hlatky MA: Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Am Heart J. 2007, 154 (6): 1052-1058. 10.1016/j.ahj.2007.05.021.
43. Siegerink B, Algra A, Rosendaal FR: Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women. Br J Haematol. 2009, 146 (4): 459-461. 10.1111/j.1365-2141.2009.07805.x.
44. Rallidis LS, Politou M, Komporozos C, Panagiotakos DB, Belessi CI, Travlou A, Lekakis J, Kremastinos DT: Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost. 2008, 99 (6): 1085-1089.
45. Doggen CJ, Rosendaal FR, Meijers JC: Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood. 2006, 108 (13): 4045-4051. 10.1182/blood-2005-12-023697.
46. Minnema MC, Peters RJ, de Winter R, Lubbers YP, Barzegar S, Bauer KA, Rosenberg RD, Hack CE, ten Cate H: Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2000, 20 (11): 2489-2493. 10.1161/01.ATV.20.11.2489.
47. Mannucci PM, Asselta R, Duga S, Guella I, Spreafico M, Lotta L, Merlini PA, Peyvandi F, Kathiresan S, Ardissino D: The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease. J Thromb Haemost. 2010, 8 (10): 2116-2121. 10.1111/j.1538-7836.2010.03982.x.
48. Dowaidar M, Settin A: Risk of myocardial infarction related to factor V Leiden mutation: a meta-analysis. Genet Test Mol Biomarkers. 2010, 14 (4): 493-498. 10.1089/gtmb.2010.0017.
49. Mannila MN, Lovely RS, Kazmierczak SC, Eriksson P, Samnegard A, Farrell DH, Hamsten A, Silveira A: Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost. 2007, 5 (4): 766-773. 10.1111/j.1538-7836.2007.02406.x.
50. Jacquemin B, Antoniades C, Nyberg F, Plana E, Muller M, Greven S, Salomaa V, Sunyer J, Bellander T, Chalamandaris AG, et al: Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol. 2008, 52 (11): 941-952. 10.1016/j.jacc.2008.06.016.
51. Ulrich MM, Janssen AM, Daemen MJ, Rappaport L, Samuel JL, Contard F, Smits JF, Cleutjens JP: Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol. 1997, 29 (9): 2533-2543. 10.1006/jmcc.1997.0486.
52. van Dijk A, Niessen HW, Ursem W, Twisk JW, Visser FC, van Milligen FJ: Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose-derived stem cells. Cell Tissue Res. 2008, 332 (2): 289-298. 10.1007/s00441-008-0573-0.
53. Aleil B, Mossard JM, Wiesel ML, Lanza F, Cazenave JP: Increased plasma levels of soluble platelet glycoprotein V in patients with acute myocardial infarction. J Thromb Haemost. 2003, 1 (8): 1846-1847. 10.1046/j.1538-7836.2003.00319.x.
54. Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Freyssinet JM, Toti F: Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost. 2004, 91 (2): 345-353.
55. Tekin D, Dursun AD, Xi L: Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta pharmacologica Sinica. 2010, 31 (9): 1085-1094. 10.1038/aps.2010.132.
56. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA: Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol. 2005, 46 (11): 2116-2124. 10.1016/j.jacc.2005.08.045.
57. Wouters D, Wagenaar-Bos I, van Ham M, Zeerleder S: C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert opinion on biological therapy. 2008, 8 (8): 1225-1240. 10.1517/14712598.8.8.1225.
58. Rennie JA, Crawford GP, Ogston D: Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol. 1976, 29 (7): 639-641. 10.1136/jcp.29.7.639.
59. Szkodzinski J, Hudzik B, Osuch M, Romanowski W, Szygula-Jurkiewicz B, Polonski L, Zubelewicz-Szkodzinska B: Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart and vessels. 2011, 26 (4): 399-407. 10.1007/s00380-010-0076-2.
60. Yang ZQ, Xu YQ, Linden J, Kron IL, French BA: Reduced Myocardial Infarct Size in Interferon-Gamma Knock-out Mice Implicates CD4+T Cells in Reperfusion Injury. Circulation. 2009, 120 (18): S1165-S1166.
61. Nawata J, Ohno I, Isoyama S, Suzuki J, Miura S, Ikeda J, Shirato K: Differential expression of alpha 1, alpha 3 and alpha 5 integrin subunits in acute and chronic stages of myocardial infarction in rats. Cardiovascular Research. 1999, 43 (2): 371-381. 10.1016/S0008-6363(99)00117-0.
62. Sahul Z, Dione DP, Dobrucki L, Kalinowski L, Brennan M, Mekkaoui C, Cavaliere P, Hawley C, Hu X, Haramis H, et al: Targeted alpha-v integrin imaging defines spatial and temporal changes in the angiogenic process post myocardial infarction. Circulation. 2006, 114 (18): 499-499.
63. Siegerink B, Rosendaal FR, Algra A: High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study. Journal of Thrombosis and Haemostasis. 2012, 10 (11): 2409-2412. 10.1111/j.1538-7836.2012.04927.x.
64. Ito H, Hayashi I, Izumi T, Majima M: Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br J Pharmacol. 2003, 138 (1): 225-233. 10.1038/sj.bjp.0705013.
65. Xie Y, Chen J, Han P, Yang P, Hou J, Kang YJ: Immunohistochemical detection of differentially localized up-regulation of lysyl oxidase and down-regulation of matrix metalloproteinase-1 in rhesus monkey model of chronic myocardial infarction. Exp Biol Med (Maywood). 2012, 237 (7): 853-859. 10.1258/ebm.2012.012070.
66. Lerman RH, Apstein CS, Kagan HM, Osmers EL, Chichester CO, Vogel WM, Connelly CM, Steffee WP: Myocardial healing and repair after experimental infarction in the rabbit. Circ Res. 1983, 53 (3): 378-388. 10.1161/01.RES.53.3.378.
67. Antoniak S, Pawlinski R, Mackman N: Protease-activated receptors and myocardial infarction. IUBMB life. 2011, 63 (6): 383-389. 10.1002/iub.441.
68. Zhong B, Wang DH: Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors. Am J Physiol Regul Integr Comp Physiol. 2009, 297 (6): R1681-1690. 10.1152/ajpregu.90746.2008.
69. Seqqat R, Rafiq K, Hanscom M, Kunapuli SP, Steinberg SF, Houser SR, Sabri A: Protease activated receptor-4 regulates post-infarction ventricular remodeling and cardiac function. Circulation. 2007, 116 (16): 45-45.
70. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG: The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006, 48 (11): 2315-2323. 10.1016/j.jacc.2006.07.060.
71. Edelberg JM, Lee SH, Kaur M, Tang L, Feirt NM, McCabe S, Bramwell O, Wong SC, Hong MK: Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation. 2002, 105 (5): 608-613. 10.1161/hc0502.103672.
72. Dymicka-Piekarska V, Kemona H, Mantur M, Stogowski A, Kemona-Chetnik I, Bychowski J: Platelet factor 4 as a marker of platelet activation in patients with acute myocardial infarction. Roczniki Akademii Medycznej w Bialymstoku. 2000, 45: 96-103.
73. Kuijpers PM, Hamulyak K, Strik JJ, Wellens HJ, Honig A: Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry research. 2002, 109 (2): 207-210. 10.1016/S0165-1781(02)00017-3.
74. Fedi S, Sofi F, Brogi D, Tellini I, Cesari F, Sestini I, Gazzini A, Comeglio M, Abbate R, Gensini GF: Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost. 2003, 90 (6): 1173-1178.
75. Le Cam-Duchez V, Soria C, Sollier CBD, Borg JY, Coudert M, Montalescot G, Esposito G, Drouet L, Collet JP: Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level. Thromb Haemostasis. 2009, 102 (1): 131-136.
76. Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, Frangogiannis NG: Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction. Circulation Research. 2010, 107 (3): 418-U176. 10.1161/CIRCRESAHA.109.216101.
77. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG: Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. Journal of Molecular and Cellular Cardiology. 2001, 33 (6): 1191-1207. 10.1006/jmcc.2001.1383.
78. Singla DK, Singla RD, Lamm S, Glass C: TGF-beta 2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium. Am J Physiol-Heart C. 2011, 300 (4): H1442-H1450. 10.1152/ajpheart.00917.2010.
79. Bujak M, Frangogiannis NG: The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007, 74 (2): 184-195. 10.1016/j.cardiores.2006.10.002.
80. Okada H, Takemura G, Kosai KI, Li YW, Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, et al: Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation. 2005, 111 (19): 2430-2437. 10.1161/01.CIR.0000165066.71481.8E.
81. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA: Thrombomodulin gene mutations associated with myocardial infarction. Circulation. 1997, 96 (1): 15-18. 10.1161/01.CIR.96.1.15.
82. Chao TH, Li YH, Chen JH, Wu HL, Shi GY, Tsai WC, Chen PS, Liu PY: Relation of thrombomodulin gene polymorphisms to acute myocardial infarction in patients <= 50 years of age. American Journal of Cardiology. 2004, 93 (2): 204-207. 10.1016/j.amjcard.2003.09.039.
83. Sezaki S, Hirohata S, Iwabu A, Nakamura K, Toeda K, Miyoshi T, Yamawaki H, Demircan K, Kusachi S, Shiratori Y, et al: Thrombospondin-1 is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion. Exp Biol Med. 2005, 230 (9): 621-630.
84. Zwicker JI, Peyvandi F, Palla R, Lombardi R, Canciani MT, Cairo A, Ardissino D, Bernardinelli L, Bauer KA, Lawler J, et al: The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood. 2006, 108 (4): 1280-1283. 10.1182/blood-2006-04-015701.
85. Stavropoulou A, Philippou A, Halapas A, Sourla A, Pissimissis N, Koutsilieris M: uPA, uPAR and TGFbeta(1) expression during early and late post myocardial infarction period in rat myocardium. In vivo. 2010, 24 (5): 647-652.
86. Minami E, Castellani C, Malchodi L, Deem J, Bertko K, Meznarich J, Dishmon M, Murry CE, Stempien-Otero A: The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling. J Mol Cell Cardiol. 2010, 49 (3): 516-524. 10.1016/j.yjmcc.2010.03.022.
87. Huebener P, Abou-Khamis T, Zymek P, Bujak M, Ying X, Chatila K, Haudek S, Thakker G, Frangogiannis NG: CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol. 2008, 180 (4): 2625-2633. 10.4049/jimmunol.180.4.2625.
88. Huang SS, Huang PH, Chen YH, Sung SH, Chiang KH, Chen JW, Lin SJ: Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction. Coron Artery Dis. 2008, 19 (8): 597-602. 10.1097/MCA.0b013e3283155579.
89. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Holm H, Ding EL, Johnson T, et al: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012, 380 (9841): 572-580. 10.1016/S0140-6736(12)60312-2.
90. Camors E, Monceau V, Charlemagne D: Annexins and Ca2+ handling in the heart. Cardiovasc Res. 2005, 65 (4): 793-802. 10.1016/j.cardiores.2004.11.010.
91. Spencer JA, Hacker SL, Davis EC, Mecham RP, Knutsen RH, Li DY, Gerard RD, Richardson JA, Olson EN, Yanagisawa H: Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA. 2005, 102 (8): 2946-2951. 10.1073/pnas.0500058102.
92. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, Martinoli E, Carlo E, Balconi G, Fiordaliso F, et al: Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol. 2005, 25 (4): 692-697. 10.1161/01.ATV.0000156402.52029.ce.
93. Sawaki D, Suzuki T, Aizawa K, Matsumura T, Munemasa Y, Ishida J, Fridman SL, Nagai R: KLF6 Modulates Recruitment and Polarization of Inflammatory Cells Through Cardiomyocytes in Initiation of Cardiac Fibrosis. Circulation. 2011, 124 (21):
94. Cornelissen I, Palmer D, David T, Wilsbacher L, Concengco C, Conley P, Pandey A, Coughlin SR: Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis. Proc Natl Acad Sci USA. 2010, 107 (43): 18605-18610. 10.1073/pnas.1013309107.
95. Brenner B, Sanchez-Vega B, Wu SM, Lanir N, Stafford DV, Solera J: A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood. 1998, 92 (12): 4554-4559.